Will GLP-1 Work Again After Stopping? What the Penn Medicine Study Means for Restarters

Many people were alarmed by headlines saying that stopping and restarting a GLP-1 could make it work less well.

The forced-off-ramp crisis has a new worry, and it's not just weight regain.

In March 2026, Penn Medicine researchers published a study in JCI Insight (Son et al.) that drew a lot of attention: in mice, repeatedly stopping and restarting semaglutide led to less weight loss with each cycle. It's an early mouse study, and it hasn't been tested in people.

For patients being forced off their medication by coverage changes (for example, CVS Caremark dropped Zepbound from its standard formulary effective July 1, 2025), this raises a worrying question. The risk isn't just "I might regain weight." It's "would it work as well if I restart?"

Here's what the research actually says, what it doesn't, and what you can do to protect your progress if you're facing a forced stop.

What the Penn Medicine Study Actually Found

The study (Son et al., JCI Insight, March 2026) was done in mice. Mice that went through repeated cycles of stopping and restarting semaglutide lost less weight with each cycle.

What we don't know yet: whether the same thing happens in people, whether the length of a break matters, or whether it applies to tirzepatide. Until there's human data, treat it as an early signal, not a rule.

The Off-Ramp Narratives Collide

The GLP-1 news cycle now carries two messages about stopping:

For patients making decisions about their GLP-1 future, the mixed messages can be paralyzing.

The truth is more nuanced. In the STEP 1 extension, people regained on average about two-thirds of the weight they had lost within a year of stopping semaglutide. In SURMOUNT-4 (JAMA 2024), people switched from tirzepatide to placebo gained 14.0% of their body weight over 52 weeks, while those who continued lost a further 5.5%. Individual results vary, and habits matter. Whether a second course works as well as the first in people is still unknown.

What Restarters Report

Online, some restarters describe weaker appetite suppression or more GI side effects when they go back on, while others say it works much as before. These are individual stories, not data, and they can't tell us whether a break of any particular length matters.

How to Protect Your Progress If You're Forced Off

If you're facing a forced stop due to insurance, cost, or supply issues, you have more control than you think. The goal is keeping any gap short while maintaining your habits.

1. Talk to Your Prescriber Before Coverage Ends

If your insurance is dropping coverage on a specific date, talk to your prescriber early. Ask:

• Whether a bridge prescription or another covered option is available
• Whether a gradual taper makes sense for you, rather than stopping all at once
• Whether they can file a formulary exception request or appeal

2. Plan for Continuity

Practical options to discuss with your prescriber:

• Self-pay programs: manufacturer self-pay programs may help cover a gap. Check LillyDirect / NovoCare for current prices
• Copies made by compounding pharmacies: the FDA ended the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025, so mass compounding of copies is no longer permitted. Ask your prescriber about FDA-approved options instead
• Don't stretch your supply: don't change your dose or the spacing between injections without your prescriber

3. Protect Muscle and Metabolic Health During the Gap

What you do during a forced break matters. Keeping up exercise and protein helps protect muscle and makes it easier to hold your weight.

• Maintain resistance training: 3x/week minimum. Muscle is your metabolic insurance policy
• Hold the protein floor: around 100g/day helps protect muscle (if you have kidney disease, ask your clinician what's right for you)
• Weigh in weekly: catch regain early. A small early bump is often water and glycogen; a steady climb in your weekly average is the signal to act and talk to your prescriber
• Track food noise patterns: if food noise returns, log when it hits hardest. This helps your prescriber when you talk about next steps

When Restarting: What to Expect the Second Time

If you restart, adjust your expectations:

1. Your prescriber sets your restart dose: 2.5 mg tirzepatide and 0.25 mg semaglutide are the label starting doses, and your prescriber decides where you restart and how fast you move up based on your break and how you tolerated the medication before
2. Give it time: it can take a few months to get back to your previous dose, at whatever pace your prescriber sets
3. Weaker initial response: the first weeks back may feel less dramatic than your first round. This doesn't mean it won't work
4. Watch for side effects: some restarters report more pronounced GI symptoms when going back on. Tell your prescriber about side effects

FAQ